HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing-Wen Xu Selected Research

Jing-Wen Xu Research Topics

Disease

3Neoplasms (Cancer)
01/2018 - 12/2014
2COVID-19
04/2021 - 01/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2018
1Wounds and Injuries (Trauma)
01/2021
1Carcinoma (Carcinomatosis)
12/2018
1Hepatocellular Carcinoma (Hepatoma)
12/2014
1Liver Neoplasms (Liver Cancer)
12/2014
1Heart Failure
05/2014
1Periodontitis
07/2002
1Bone Resorption
07/2002
1Alveolar Bone Loss
07/2002

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
01/2021 - 07/2002
2gamma-sitosterol (beta-sitosterol)IBA
01/2020 - 01/2018
2GemcitabineFDA Link
01/2020 - 01/2018
1Antiviral Agents (Antivirals)IBA
04/2021
1dalbavancinIBA
01/2021
1VaccinesIBA
01/2021
1SARS-CoV-2 spike proteinIBA
01/2021
1BromidesIBA
12/2018
1Paclitaxel (Taxol)FDA LinkGeneric
12/2018
1polymethacrylic acid (PMAA)IBA
05/2016
1MicellesIBA
05/2016
1TubulinIBA
12/2014
15- (3- hydroxy- 4- methoxyphenyl)- 4- (3,4,5- trimethoxyphenyl)- 3H- 1,2- dithiol- 3- oneIBA
12/2014
1Matrix Metalloproteinases (MMPs)IBA
07/2002
1TetracyclinesIBA
07/2002
1EndotoxinsIBA
07/2002
1Doxycycline (Periostat)FDA LinkGeneric
07/2002
1goat lung surfactant extractIBA
07/2002
1GelatinasesIBA
07/2002
1GelatinIBA
07/2002

Therapy/Procedure

1Patient Readmission
05/2014